Recombinant BCAT4 showed high efficiency with Met and its derivatives and the corresponding 2-oxo acids suggesting its participation in the chain elongation pathway of Met-derived GSL biosynthesis. This was substantiated by in vivo analysis of two BCAT4 T-DNA knockout mutants in which Met-derived aliphatic GSL accumulation is reduced by nearly 50% (Schuster et al. 2006)